FREDERICK, Md., Dec. 15, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, is calling upon cruise lines to improve decontamination and adopt hospital-grade technology like SteraMist as a compromise-free standard for advanced maritime decontamination. “The question should no longer be if cruise lines can prevent health outbreaks, but how often and how comprehensively they are utilizing hospital-grade disinfecti ...

Summary of TOMI Environmental Solutions Conference Call Company Overview - **Company Name**: TOMI Environmental Solutions - **Ticker**: TOMZ - **Industry**: Disinfection and Decontamination - **Product**: SteraMist, an eco-friendly disinfection solution developed from DARPA technology Core Points and Arguments - **Product Efficacy**: SteraMist utilizes a low-percentage hydrogen peroxide (7.8%) converted through a cold plasma arc to create hydroxyl radicals that effectively neutralize pathogens, including spores and viruses, without leaving any residue [2][3][4] - **Market Opportunity**: The global market for disinfection is vast, spanning multiple industries including biotech, food and beverages, commercial services, and healthcare, with significant growth expected [4][16] - **Competitive Landscape**: Major competitors include STERIS and Bioquell, with TOMI positioned to outperform due to its unique technology and faster, more effective disinfection capabilities [5][10] - **Client Base**: Notable clients include Pfizer, Merck, NASA, and various government agencies, which validate the product's effectiveness and reliability [3][19] - **Regulatory Compliance**: The company adheres to stringent regulations, including FDA and EMA compliance, which enhances its credibility in the market [16][20] Financial Performance - **Revenue Growth**: Revenues increased by 38% over pre-COVID levels, with a 40% growth in the first half of 2025 compared to the same period in 2024 [21][14] - **Margins**: The company maintains gross margins of approximately 60%-62% [10][23] - **Recurring Revenue Model**: The business model is based on a "razor and blade" approach, where equipment sales drive recurring revenue from consumables [10][25] Market Segments - **Biotechnology and Life Sciences**: This segment is the largest revenue generator, including applications in pharmaceuticals and clean rooms [5][6] - **Food Safety**: Growing segment with increasing demand for sanitation solutions due to stricter regulations and food safety concerns [18][19] - **Healthcare**: Significant potential for growth, especially in hospitals, where SteraMist has demonstrated effectiveness in reducing infection rates [20][21] Future Outlook - **Market Expansion**: The company is focused on expanding its sales force and enhancing training programs to penetrate more healthcare facilities and other verticals [22][23] - **Technological Advancements**: Ongoing development of custom integration units and partnerships with laboratory equipment manufacturers to embed SteraMist technology [10][11] - **Regulatory Tailwinds**: Increased focus on biosecurity and infection control post-COVID is expected to drive demand for SteraMist solutions [16][24] Additional Insights - **Case Studies**: Successful case studies, such as the reduction of C. diff cases in hospitals, provide strong evidence of product effectiveness [20] - **Environmental Impact**: SteraMist's eco-friendly profile, with water and humidity as the only byproducts, positions it favorably against traditional disinfection methods [29][30] - **Global Health Concerns**: The company is prepared to address potential outbreaks and pandemics, leveraging its technology to provide effective solutions [24] This summary encapsulates the key points discussed during the TOMI Environmental Solutions conference call, highlighting the company's strengths, market opportunities, and future growth potential.

FREDERICK, Md., Dec. 04, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, announced today that it will be presenting at the Sidoti Year End Investor Conference being held virtually on December 10-11, 2025. Dr. Halden Shane, CEO and Chairman of the Board, and David Vanston, Chief Financial Officer, wil ...

Group 1 - TOMI Environmental Solutions, Inc. will present at the LD Micro Main Event XIX on October 21, 2025, at 10:00 AM PT [1][2] - The event will take place from October 19 to 21, 2025, at the Hotel del Coronado in San Diego, California, featuring around 120 companies [3][4] - Dr. Halden Shane, CEO and Chairman of the Board, will be delivering the presentation for TOMI [1] Group 2 - TOMI specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, marketed under the SteraMist brand [5] - The BIT solution utilizes a low percentage of hydrogen peroxide as its active ingredient, employing patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [5] - TOMI's products are designed for a wide range of applications, including hospitals, biosafety labs, pharmaceutical facilities, and various commercial settings [5]

Core Insights - TOMI Environmental Solutions, Inc. has appointed Mr. Harold W. Paul to its Board of Directors, effective immediately, succeeding Ms. Kelly J. Anderson who resigned as of September 30, 2025 [1][3] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, marketed under the SteraMist brand [1][4] - The BIT solution utilizes a low percentage of hydrogen peroxide as its active ingredient and employs patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [4] Leadership Experience - Mr. Paul brings over 40 years of legal and securities expertise, along with extensive board leadership experience across various industries, having previously served on TOMI's Board from 2009 to 2021 [2] - He has advised numerous publicly traded companies as outside legal counsel and has served on the boards of six public companies [2] Strategic Importance - The CEO of TOMI, Dr. Halden Shane, expressed that Mr. Paul's knowledge of securities law and corporate governance will provide valuable insights as the company advances its strategy and expands its impact in critical industries [3]

Core Insights - TOMI Environmental Solutions, Inc. has appointed Mr. Francesco Fragasso to its Board of Directors, effective immediately, succeeding Mr. Walter Johnsen who has resigned [1][2][4] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, marketed under the SteraMist brand [5] - The BIT solution utilizes a low percentage of hydrogen peroxide as its active ingredient and employs patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [5] Leadership Experience - Mr. Fragasso brings over 25 years of global financial and operational leadership experience across various industries, having served as CFO for multiple companies including Hamilton Thorne Ltd. and Fluence Corporation Ltd. [3] - He is a European Chartered Public Accountant and holds an MBA from Boston University, along with a Bachelor and Master of Science in Business and Economics from Università Bocconi in Milan, Italy [3] Strategic Importance - The CEO of TOMI, Dr. Halden Shane, emphasized that Mr. Fragasso's extensive experience in guiding innovative companies through growth and transformation will be a significant asset for TOMI as it continues to expand its presence across multiple industries [4]

Core Insights - TOMI Environmental Solutions, Inc. is participating in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16 and 17, 2025, with a presentation by CEO Dr. Halden Shane [1] - The company specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, marketed under the SteraMist brand [4] Company Overview - TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) focuses on providing environmental solutions for disinfection, utilizing its BIT platform, which was developed with the Defense Advanced Research Projects Agency (DARPA) [4] - The BIT solution employs a low percentage of hydrogen peroxide as its active ingredient, utilizing patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [4] - TOMI's products cater to a wide range of sectors, including hospitals, biosafety labs, pharmaceutical facilities, commercial buildings, schools, and emergency services [4] Conference Details - The live webcast of TOMI's presentation will be available online, with a replay accessible afterward [2] - The iAccess Alpha conference features companies recommended by investors, providing opportunities for one-on-one meetings with TOMI [3]

Core Insights - TOMI Environmental Solutions, Inc. will participate in the H.C. Wainwright 25th Annual Global Investment Conference from September 8-10, 2025, in New York City [1][2] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, marketed under the SteraMist brand [3] - The BIT solution utilizes a low percentage of hydrogen peroxide as its active ingredient and incorporates patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [3] - TOMI's products are applicable in various environments, including hospitals, biosafety labs, pharmaceutical facilities, schools, and commercial buildings [3]

Financial Results - For Q2 2025, net sales were $1,031,000, a decrease from $3,013,000 in Q2 2024, reflecting a decline in product sales due to deferred capital expenditures by customers [5][22] - For the first half of 2025, net sales were $2,608,000, down from $4,127,000 in the same period of 2024 [5][22] - Gross profit margin improved to 66% in Q2 2025, compared to 62% in Q2 2024, attributed to a favorable product mix [5][22] - The company reported an operating loss of $(1,133,000) for Q2 2025, compared to an income of $122,000 in Q2 2024 [5][22] - Net loss for Q2 2025 was $(1,238,000) or $(0.06) per share, compared to a net income of $30,000 or $0.00 per share in Q2 2024 [5][22] Business Highlights - Service and training revenue increased by 33% year-over-year in Q2 2025 and by 46% in the first half of 2025, indicating strong demand for decontamination services [5][6] - SteraMist solution sales rose by 40% year-over-year for the first half of 2025 [5] - The company achieved nearly 20% of Q2 revenue from international markets, demonstrating ongoing global expansion [5][6] Strategic Initiatives - The company is focused on expanding recurring service contracts and exploring new product lines to generate steady income [12] - Plans to strengthen the corporate team and expand talent in key areas such as sales and customer support are underway [9] - The company is negotiating approximately $2 million in new custom and integrated contracts, with bids expected to close before year-end [5] Leadership and Recognition - David Vanston was appointed as Chief Financial Officer in May 2025, bringing extensive experience to support growth and capital strategy [7] - The company received the "Disinfection and Decontamination Products Company of the Year" award by MedTech Outlook in June 2025, highlighting its commitment to excellence [6] Liquidity and Capital Access - As of June 30, 2025, the company had working capital of $2.8 million, with cash used in operations improving by over $1 million compared to the prior year [8] - The company completed a $435,000 convertible note financing in the first half of 2025 to support growth initiatives [8]

Core Insights - TOMI Environmental Solutions, Inc. reported a 42% increase in revenue for Q1 2025 compared to the previous quarter, driven by strong demand for its product lines and recurring solution sales [2][3] - The company achieved a gross margin of 60.4%, slightly up from 60.2% in the prior year, and reduced its operating loss to $(754,000) from $(1,226,000) year-over-year [6] - Net loss decreased to $(256,000) or $(0.01) per share, compared to $(1,310,000) or $(0.07) per share in the same period last year [6] Financial Performance - Net sales for Q1 2025 were $1,577,000, up from $1,114,000 in Q1 2024, marking a significant year-over-year growth [6] - SteraMist product-based revenues increased to $1,000,000 from $743,000, reflecting a $257,000 rise due to heightened demand for various SteraMist solutions [6] - Service-based revenue also grew by 56%, reaching $577,000 compared to $371,000 in the prior year [6] Market Trends and Business Development - Domestic revenue surged by 80% to $1,192,000 from $662,000, attributed to increased demand for solutions and services [6] - The sales backlog as of March 31, 2025, was $1,225,000, an increase of $348,000 from December 31, 2024 [6] - A significant contract was secured for a SteraMist iHP Custom Engineered System at a university in Rhode Island, valued at approximately $450,000 [6] Strategic Partnerships and Expansion - TOMI announced the deployment of SteraMist iHP technology at NASA Johnson Space Center, indicating expansion into the aerospace sector [6] - An OEM partnership with Pharma Biotech System Components was established to enhance the SteraMist Integrated System [6] - The company is expanding into aquaculture with a new partner, Algafeed, further diversifying its market reach [7]